Anika Therapeutics Inc logo

ANIK - Anika Therapeutics Inc Share Price

$45.22 -0.7  -1.5%

Last Trade - 5:45pm

Sector
Healthcare
Size
Mid Cap
Market Cap £501.9m
Enterprise Value £369.1m
Revenue £85.7m
Position in Universe 2810th / 6416
Bullish
Bearish
Unlock ANIK Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ANIK Revenue Unlock ANIK Revenue

Net Income

ANIK Net Income Unlock ANIK Revenue

Normalised EPS

ANIK Normalised EPS Unlock ANIK Revenue

PE Ratio Range

ANIK PE Ratio Range Unlock ANIK Revenue

Dividend Yield Range

ANIK Dividend Yield Range Unlock ANIK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ANIK EPS Forecasts Unlock ANIK Revenue
Profile Summary

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated June 6, 2018
Public Since May 16, 1985
No. of Shareholders: 121
No. of Employees: 133
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 14,269,367
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ANIK Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ANIK
Upcoming Events for ANIK
Similar to ANIK
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.